Novel Boron-containing Drugs Laboratory

Peking University Boya Distinguished Professor

Principal Investigator, Peking-Tsinghua Center for Life Sciences

Recipient of The National Science Fund for Distinguished Young Scholars of China

The laboratory aims to solve the bottleneck problem of boron-containing drugs for boron neutron capture therapy (BNCT for short) in China and achieve technological advancements. It focuses on selecting a series of novel boron drug molecules with independent intellectual property rights, cutting-edge designs, and superior therapeutic effects for clinical transformation. This effort will help China transition from following to leading in the global BNCT field.